品牌分类
品牌咨询
联系方式
公司地址
苏州工业园区生物纳米园A4#216
联系电话
4000-520-616 / 18915418616
传真号码
0512-67156496
电子邮箱
info@ebiomall.com
公司网址
https://www.ebiomall.com
商品描述
- Specification
- Product Description:
- FUS Split CISH Probe is designed for the qualitative detection of translocations involving the human FUS gene at 16p11.2 in formalin-fixed, paraffin-embedded specimens by chromogenic in situ hybridization (CISH).
- Recommend Usage:
- The product is ready-to-use. No reconstitution, mixing, or dilution is required. Bring probe to room temperature (18-25°C) and mix briefly before use.
- Supplied Product:
- Reagent Provided:This Probe is composed of:1. Digoxigenin-labeled polynucleotides, which target sequences mapping in 16p11.2* (chr16:30,663,949-30,840,569) distal to the FUS breakpoint region.2. Dinitrophenyl-labeled polynucleotides, which target sequences mapping in 16p11.2* (chr16:31,213,259-31,927,155) proximal to the FUS breakpoint region. 3. Formamide based hybridization buffer.*according to Human Genome Assembly GRCh37/hg19
- Storage Instruction:
- Store at 2-8°C in an upright position. Return to storage conditions immediately after use.
- Note:
- The probe is intended to be used in combination with the CISH Implementation Kit 2 (Catalog #: KA5366), which provides necessary reagents for specimen pretreatment and post-hybridization processing.Interpretation of results:Using the CISH Implementation Kit 2 (Cat # KA5366), hybridization signals of Digoxigenin-labeled polynucleotides appear as dark green colored distinct dots (distal to the FUS breakpoint region), and Dinitrophenyl-labeled polynucleotides appear as bright red colored distinct dots (proximal to the FUS breakpoint region).Normal situation: In interphases of normal cells or cells without a translocation involving the FUS gene region, two red/green fusion signals appear.Aberrant situation: One FUS gene region affected by a translocation is indicated by one separate distinct dot-shaped green signal and one separate distinct dot-shaped red signal.Overlapping signals may appear as brown signals. Genomic aberrations due to small deletions, duplications or inversions might result in inconspicuous signal patterns. Other signal patterns than those described above may be observed in some abnormal samples. These unexpected signal patterns should be further investigated.
- Probe Position:
- Regulatory Status:
- For research use only (RUO)
- Interpretation of Result:
- Datasheet:
Download
- Applications
- Chromogenic In Situ Hybridization (FFPE Tissue)
- Myxoid liposarcoma tissue section with translocation affecting the 16p11.2 locus as indicated by one non-rearranged red/green fusion signal, one red signal, and one separate green signal indicating the translocation.
- Application Image
- Chromogenic In Situ Hybridization (FFPE Tissue)
- enlarge
- Gene Information
- Entrez GeneID:
- 2521
- Gene Name:
- FUS
- Gene Alias:
- CHOP,FUS-CHOP,FUS1,TLS,TLS/CHOP,hnRNP-P2
- Gene Description:
- fusion (involved in t(12;16) in malignant liposarcoma)
- Omim ID:
- 137070
- Gene Ontology:
- Hyperlink
- Gene Summary:
- This gene encodes a multifunctional protein component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complex. The hnRNP complex is involved in pre-mRNA splicing and the export of fully processed mRNA to the cytoplasm. This protein belongs to the FET family of RNA-binding proteins which have been implicated in cellular processes that include regulation of gene expression, maintenance of genomic integrity and mRNA/microRNA processing. Alternative splicing results in multiple transcript variants. Defects in this gene result in amyotrophic lateral sclerosis type 6. [provided by RefSeq
- Other Designations:
- FUS-CHOP fusion protein,FUS-CHOP protein fusion,Fusion gene in myxoid liposarcoma,fus-like protein,fus/tls-chop oncogene,heterogeneous nuclear ribonucleoprotein P2,translocated in liposarcoma
- Related Disease
- Amyotrophic Lateral Sclerosis
- Azoospermia
- Cognition Disorders
- Diabetes Mellitus, Type 2
- Frontotemporal Dementia
- Frontotemporal Lobar Degeneration
- Genetic Predisposition to Disease
- Infertility, Male
- Neoplasms
- Neuropsychological Tests
- Obesity
- Obesity
- Oligospermia
- Overweight
- Parkinsonian Disorders
- Prostate cancer
